WALTHAM, Mass., April 1, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that it has been added to the Russell 3000® Index, which measures the performance of the 3,000 largest publicly-traded U.S. companies based on total market capitalization. The Russell 3000 Index is constructed to provide a comprehensive barometer of the broad market and is reconstituted annually to capture new and growing companies.
